Search Results - "Hegazy, Sahar K."

Refine Results
  1. 1

    Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients by Hegazy, Sahar K., Tharwat, Samar, Hassan, Ahmed H.

    Published in Open medicine (Warsaw, Poland) (09-08-2023)
    “…Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against…”
    Get full text
    Journal Article
  2. 2

    Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients by Hegazy, Sahar K., Tharwat, Samar, Hassan, Ahmed H.

    Published in Journal of clinical virology plus (01-06-2023)
    “…•Corona Virus induced disease – 2019 (COVID-19) disaster motivates scientific research to find a settling to this pandemic.•Various advances in immunotherapy…”
    Get full text
    Journal Article
  3. 3

    Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine by El‑Haggar, Sahar M., Hegazy, Sahar K., Abd-Elsalam, Sherief M., Bahaa, Mostafa M.

    Published in Biomedicine & pharmacotherapy (01-01-2022)
    “…Irritable bowel syndrome (IBS) is a functional gastrointestinal condition marked by chronic bowel pain or discomfort, as well as changes in abdominal motility…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis by Hegazy, Sahar K, El-Bedewy, Mohamed, Yagi, Akira

    Published in World journal of gastroenterology : WJG (07-05-2012)
    “…AIM:To investigate the anti-oxidative and anti-fibrotic effects of aloe vera in patients with liver fibrosis.METHODS:Aloe vera high molecular weight…”
    Get full text
    Journal Article
  6. 6

    Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis by Hegazy, Sahar K

    Published in World journal of gastroenterology : WJG (07-09-2010)
    “…AIM: To demonstrate the therapeutic effect of probiotics in patients with ulcerative colitis (UC), and their effect on inflammatory mediators and nuclear…”
    Get full text
    Journal Article
  7. 7

    Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer by Hegazy, Sahar K., El-Azab, Gamal A., Zakaria, Fatma, Mostafa, Mohamed F., El-Ghoneimy, Reham A.

    Published in Life sciences (1973) (15-06-2022)
    “…Metastatic colorectal cancer (mCRC) predominantly contributes to cancer-related mortalities secondary to distant metastasis. This study aimed at investigating…”
    Get full text
    Journal Article
  8. 8

    Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study by El‑Haggar, Sahar M., Hegazy, Sahar K., Maher, Maha M, Bahgat, Monir M, Bahaa, Mostafa M.

    Published in International immunopharmacology (10-09-2024)
    “…UC is triggered by various stimuli such as oxidative stress, antigens, immunity, and environmental factors. These stimuli release inflammatory cytokines such…”
    Get full text
    Journal Article
  9. 9

    Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study by Khrieba, Mohannad O., Hegazy, Sahar K., Mustafa, Wessam, El‑Haggar, Sahar M.

    Published in Inflammopharmacology (01-12-2024)
    “…Background The clinical presentations of Parkinson’s disease (PD), a chronic neurodegenerative condition, include bradykinesia, hypokinesia, stiffness, resting…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study by Bahaa, Mostafa M., Hegazy, Sahar K., Maher, Maha M., Bahgat, Monir M., El‑Haggar, Sahar M.

    Published in Inflammopharmacology (01-10-2024)
    “…Background Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that lasts a long time and has a variety of causes. Aim The primary aim of this study…”
    Get full text
    Journal Article
  12. 12

    Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma by Hegazy, Sahar K., El-Haggar, Sahar M., Alhassanin, Suzan A., El-berri, Eman I.

    “…The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for…”
    Get full text
    Journal Article
  13. 13

    Effect of genetic polymorphisms on the development of secondary failure to sulfonylurea in Egyptian patients with type 2 diabetes by El-sisi, Alaa E., Hegazy, Sahar K., Metwally, Shereen S., Wafa, Alaa M., Dawood, Naglaa A.

    “…Objective: This study investigated the possibility that genetic factors, such as polymorphism of K inward rectifier subunit (Kir6.2), E23K, and Arg972…”
    Get full text
    Journal Article
  14. 14

    Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome by El‑Haggar, Sahar M., Hegazy, Sahar K., M. Abd‐Elsalam, Sherief, Bahaa, Mostafa M

    “…What is known and objectives There is clear evidence for an association between irritable bowel syndrome (IBS) and visceral hypersensitivity. This clinical…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers by Hegazy, Sahar K., Mabrouk, Mokhtar M., Elsisi, Alaa E., Mansour, Noha O.

    Published in European journal of clinical pharmacology (01-09-2012)
    “…Objective Montelukast, a leukotriene receptor antagonist, is used in the treatment of asthma. The objective of the study reported here was to determine whether…”
    Get full text
    Journal Article
  17. 17

    Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes by Hegazy, Sahar K, Tolba, Osama A, Mostafa, Tarek M, Eid, Manal A, El-Afify, Dalia R

    Published in The review of diabetic studies (2013)
    “…Oxidative stress plays an important role in the development of diabetic cardiomyopathy. Alpha-lipoic acid (ALA) is a powerful antioxidant that may have a…”
    Get full text
    Journal Article
  18. 18

    Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women by Hegazy, Sahar Kamal

    Published in Journal of bone and mineral metabolism (01-03-2015)
    “…Osteoporosis is the most important metabolic bone disease in patients with diabetes mellitus. Several studies have documented that metformin is osteogenic in…”
    Get full text
    Journal Article
  19. 19

    EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS by K HEGAZY, SAHAR, A ELBEDEWY, TAMER, M SAMI, HAIDY

    “…Objective: Endothelial dysfunction is afflicted to the maturation of arteriosclerosis and type 2 diabetes mellitus (T2DM) vascular complications. This study…”
    Get full text
    Journal Article
  20. 20